<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-JDY0HG2P</identifier><date>2014</date><creator>Horvat-Ledinek, Alenka</creator><creator>Rot, Uroš</creator><creator>Šega, Saša</creator><relation>documents/doc/J/URN_NBN_SI_doc-JDY0HG2P_001.pdf</relation><relation>documents/doc/J/URN_NBN_SI_doc-JDY0HG2P_001.txt</relation><format format_type="issue">7/8</format><format format_type="volume">83</format><format format_type="type">article</format><format format_type="extent">str. 538-543</format><identifier identifier_type="ISSN">1318-0347</identifier><identifier identifier_type="COBISSID">1700012</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-JDY0HG2P</identifier><language>slv</language><publisher>Slovensko zdravniško društvo</publisher><source>Zdravniški vestnik</source><rights>BY-NC</rights><subject language_type_id="slv">ekonomsko breme</subject><subject language_type_id="slv">imunomodulatorna terapija</subject><subject language_type_id="slv">multipla skleroza</subject><subject language_type_id="slv">napredovanje bolezni</subject><subject language_type_id="slv">zagon</subject><title>Ekonomsko breme multiple skleroze</title><title>The economic burden of multiple sclerosis</title></Record>